Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis
Open Access
- 9 July 2022
- journal article
- review article
- Published by Elsevier in eClinicalMedicine
- Vol. 51, 101545
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2020YFC0860900)
- Wuhan Science and Technology Project (2020020602012112)
- Tianjin Municipal Science and Technology Program (16PTWYHZ00030)
- Tianjin Municipal Science and Technology Program (18PTSYJC00070)
This publication has 48 references indexed in Scilit:
- Impact of the Different Preparation Methods to Obtain Human Adipose-Derived Stromal Vascular Fraction Cells (AD-SVFs) and Human Adipose-Derived Mesenchymal Stem Cells (AD-MSCs): Enzymatic Digestion Versus Mechanical CentrifugationInternational Journal of Molecular Sciences, 2019
- The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analysesMedicine, 2019
- Characteristics and Potentiality of Human Adipose-Derived Stem Cells (hASCs) Obtained from Enzymatic Digestion of Fat GraftCells, 2019
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventionsBMJ, 2016
- The Biomolecular Basis of Adipogenic Differentiation of Adipose-Derived Stem CellsInternational Journal of Molecular Sciences, 2014
- Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised QstatisticsBMC Medical Research Methodology, 2011
- Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?Transfusion Medicine and Hemotherapy, 2010
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Assessing heterogeneity in meta-analysis: Q statistic or I² index?Psychological Methods, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003